Brandon Scalea
Advertisement
Articles by Brandon Scalea
Advertisement
Latest Updated Articles
Expert Highlights Evolution of Biosimilars in OncologyPublished: June 29th 2018 | Updated:
Expert Highlights Atezolizumab/Bevacizumab Combo in RCCPublished: July 6th 2018 | Updated:
Bauml Discusses State of Immunotherapy Biomarkers in NSCLCPublished: July 10th 2018 | Updated:
Levy Highlights Benefits, Limitations of Liquid Biopsies in NSCLCPublished: July 16th 2018 | Updated:
Expert Highlights Potential of Moxetumomab Pasudotox in Hairy Cell LeukemiaPublished: July 18th 2018 | Updated:
Expert Shares Insight on Liquid Biopsies in Pediatric SarcomasPublished: July 30th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5